ERBB2 and breast carcinoma: Cyclin-dependent kinase 12 (CDK12), located on chr17q12, has a high concurrent amplification rate similar to HER2 (about 90% of HER2+ breast cancers), and the results show that CDK12 enhances CSC self-renewal in breast cancer in a manner independent of HER2.